Navigation Links
Abington Hospital-Jefferson Health Among First in State Offering Watchman Implant to Patients with Atrial Fibrillation
Date:9/23/2015

Abington Hospital-Jefferson Health is among the first in Pennsylvania to offer patients with non-valvular atrial fibrillation (AF) an alternative to long-term warfarin medication with the newly approved WATCHMAN Left Atrial Appendage Closure (LAAC) Implant.

For patients with AF who are considered suitable for warfarin by their physicians, but who have reason to seek a non-drug alternative, the Watchman LAAC Implant is an implant alternative to reduce their risk of AF-related stroke. The Watchman Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stoke may be reduced and, over time, patients may be able to stop taking warfarin.

People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the LAA. For patients with non-valvular AF, the LAA is believed to be the source of the majority of stroke-causing blood clots. If a clot forms in the LAA, it can increase one’s risk of having a stroke. Blood clots can break loose and travel in the blood stream to the brain, lungs and other parts of the body.

“The new Watchman LAAC implant provides physicians with a stroke risk reduction option for patients with non-valvular atrial fibrillation,” said Richard Borge, MD, medical director, Heart Rhythm Center at Abington Hospital. “For those seeking an alternative to warfarin, the Watchman Implant offers a potentially life-changing stroke risk treatment option, which could free them from the challenges of long-term warfarin therapy.”

Implanting the Watchman device is a one-time procedure that usually lasts about an hour. Following the procedure, patients typically need to stay in the hospital 24 hours.

About Atrial Fibrillation
Atrial Fibrillation (AF) is a heart condition where the upper chambers of the heart (atrium) beat too fast with irregular rhythm (fibrillation). AF is the most common cardiac arrhythmia, currently affecting more than five million Americans. Twenty percent of all strokes occur in patients with AF, and AF-related strokes are more frequently fatal and disabling. The most common treatment to reduce stroke risk in patients with AF is blood-thinning warfarin medication. Despite its proven efficacy, long-term warfarin medication is not well-tolerated by some patients and carries a significant risk for bleeding complications. Nearly half of AF patients eligible for warfarin are currently untreated due to tolerance and adherence issues.

The Watchman Implant is designed to close the LAA in order to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke for higher risk patients with non-valvular AF. The Watchman implant has been approved for use in Europe since 2005 and is FDA-approved in the United States. It has been implanted in more than 10,000 patients and is approved in more than 70 countries around the world.

About Abington – Jefferson Health
Abington – Jefferson Health encompasses Abington Hospital in Abington, Abington – Lansdale Hospital in Hatfield Township, two urgent Care Centers and five convenient outpatient facilities, which include Abington Health Center – Willow Grove, Abington Health Center – Warminster, Abington Health Center – Blue Bell, Abington Health Center – Lower Gwynedd and Abington Health Center – Montgomeryville. More than 1,400 physicians are on staff at both Abington Hospital and Abington – Lansdale Hospital. In addition, some physicians are members of Abington Health Physicians, an employed network of primary care physicians and specialists. Abington – Jefferson Health is part of Jefferson Health and Jefferson, a newly formed organization dedicated to providing the highest quality, compassionate clinical care for patients, educating the health professionals of tomorrow, and discovering new treatments and therapies that will define the future of health care.

Read the full story at http://www.prweb.com/releases/2015/09/prweb12979606.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Abington Memorial Hospital Recognized for Heart Failure Care
2. Abington Memorial Hospital to Become Regional Medical Campus for Drexel University College of Medicine
3. Abington Health Physician Addresses Link Between Stress and Infertility
4. New Orthopaedic & Spine Institute Unit Opens at Abington Memorial Hospital
5. Abington Health Website Named Best in Class
6. Despite Recent Study, Abington Health Expert Encourages Breastfeeding
7. Abington Health Achieves Platinum-Level in the 2014 Pennsylvania Donate Life Hospital Challenge
8. Abington Health Opens New Health Center in Lower Gwynedd
9. Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center
10. Abington Memorial Hospital Achieves New Status as Accredited Chest Pain Center
11. Abington Health: Results of trial suggest clot-busting drugs taking backseat to clot removal in treatment of ischemic strokes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... 08, 2019 , ... What unique insights can three former Surgeons General of ... in the nation? That question will be answered at ICAA 2019: Shaping the Future ... The event will take place October 10-12, 2019, at the Gaylord Palms Resort and ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon Valley Smile Solutions ... relief from this common and treatable condition. Dr. HagShenas’ goal is to treat ... with uncomfortable symptoms, including tender and bleeding gums, and to prevent gum disease from ...
(Date:10/8/2019)... ... 08, 2019 , ... As a world-renowned expert using intravital ... with the University of Maryland Department of Veterinary Medicine, continues to make new ... and his lab have discovered a new pathway by which liver macrophages called ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... and pathologists, 4medica® President Gregg Church will inform conference attendees how ... reinventing labs orders management-by starting with the right, clean patient data. The single ...
(Date:10/8/2019)... ... October 08, 2019 , ... The University of California ... Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic ... that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today ... Mandalay Bay Resort & Casino, Las Vegas on Oct. 15 – 19, 2019. ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... announced that FocalPoint Holdings, a privately-held investment and management firm specializing in ... than 8,000 ophthalmology and optometry providers Luma Health’s patient relationship technology to ...
(Date:10/8/2019)... ... ... ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, today announced ... and drive sales growth. , The following changes and new additions have been made ... to Senior Vice President of Strategic Partnerships; , Keith Clements hired ...
Breaking Medicine Technology: